NCT03204630
Completed
Not Applicable
Functional Evaluation of Two Infant Formula Supplemented With Probiotics Isolated From Breast Milk
Biosearch S.A.2 sites in 1 country236 target enrollmentJanuary 2011
ConditionsInfant Nutrition
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Infant Nutrition
- Sponsor
- Biosearch S.A.
- Enrollment
- 236
- Locations
- 2
- Primary Endpoint
- Body weight gain
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
A randomized double blinded controlled study including infants at the age of 1 month . Infants are assigned randomly to either infant formula supplemented with B. breve CECT7263 or L.fermentum CECT5716 (Probiotic groups), or the same formula without the probiotic strain (Control group). The primary outcome of the study is the body weight gain of infants. Secondary outcomes are incidence of infections, symptoms related with intestinal function, and fecal microbiota
Investigators
Eligibility Criteria
Inclusion Criteria
- •Newborn infants at term (37-42 weeks gestational age) healthy during the first month of life, for reasons unrelated to the study, abandon breastfeeding during the first month of life.
- •Signature of informed parental or guardian consent.
Exclusion Criteria
- •Allergic to the protein in cow's milk.
- •Lactose intolerant.
- •Suffering from a serious metabolic disease.
- •They have experienced or are experiencing some severe gastrointestinal disease.
- •Receive some form of chronic medication or are receiving antibiotics at the time of capture.
- •Low expectation of compliance with the study protocol.
- •allergic to any group of antibiotics.
Outcomes
Primary Outcomes
Body weight gain
Time Frame: 12 months versus baseline
Body weight gain at 12 months (grams)
Secondary Outcomes
- Length(1,2,4,6,9 and 12 months of age)
- Body weight(1,2,4,6,9 and 12 months of age)
- Incidence of infections(total incidence during intervention (11 months))
- Bacterial load in feces(1,2,4,6,9 and 12 months of age)
- Regurgitation(each 2 weeks until 6 months of age and monthly until 12 months of age)
- Fecal deposition(each 2 weeks until 6 months of age and monthly until 12 months of age)
- Infant colic(each 2 weeks until 6 months of age and monthly until 12 months of age)
- Flatulency(each 2 weeks until 6 months of age and monthly until 12 months of age)
- Hours of night sleep(each 2 weeks until 6 months of age and monthly until 12 months of age)
- Total hours of sleep/day(each 2 weeks until 6 months of age and monthly until 12 months of age)
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Effect of an Infant Formula With Synbiotics in Infants Born Via Caesarean SectionGut MicrobiotaNCT04991792HiPP GmbH & Co. Vertrieb KG486
Completed
Not Applicable
To Investigate Effects of a New Infant Formula in Healthy Term Chinese InfantsHealthy InfantsNCT03520764Danone Nutricia284
Completed
Not Applicable
Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s)Healthy InfantsNCT04962594Société des Produits Nestlé (SPN)318
Completed
Not Applicable
New Infant Formula Trial in Healthy Term Subjects on Growth, Body Composition, Tolerance and SafetyHealthyNCT01609634Danone Asia Pacific Holdings Pte, Ltd.541
Completed
Not Applicable
Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides, Beta-palmitate and Acidified MilkFormula Feeding of Healthy Full Term InfantsNCT01197365Heinz Italia SpA148